11:39
2026-06-27
cryptobriefing.com
artificial-intelligence
Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery
Nvidia's venture arm NVentures disclosed a $10.4 million stake in Generate:Biomedicines, an AI-driven drug discovery company with a Phase 3 asthma trial and FDA Fast Track oncology candidates. The inv…